Peer review reports
From: C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
Original Submission | ||
---|---|---|
8 Jun 2017 | Submitted | Original manuscript |
30 Jun 2017 | Reviewed | Reviewer Report - Anindita Chakrabarty |
4 Jul 2017 | Reviewed | Reviewer Report - Prathibha Ranganathan |
14 Jul 2017 | Reviewed | Reviewer Report - Joan Garrett |
15 Oct 2017 | Author responded | Author comments - Wei Li |
Resubmission - Version 2 | ||
15 Oct 2017 | Submitted | Manuscript version 2 |
15 Dec 2017 | Reviewed | Reviewer Report - Anindita Chakrabarty |
29 Dec 2017 | Reviewed | Reviewer Report - Prathibha Ranganathan |
3 Jan 2018 | Reviewed | Reviewer Report - Joan Garrett |
26 Feb 2018 | Author responded | Author comments - Wei Li |
Resubmission - Version 3 | ||
26 Feb 2018 | Submitted | Manuscript version 3 |
10 Apr 2018 | Reviewed | Reviewer Report - Prathibha Ranganathan |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
17 Apr 2018 | Editorially accepted | |
2 May 2018 | Article published | 10.1186/s12885-018-4387-5 |